本文へ移動
cccskills
無料GitHub で公開

endo-inpatient-cgm-initiation-high-risk

Suggests initiating inpatient continuous glucose monitoring (CGM) for select hospitalized patients at high risk for hypoglycemia, combined with periodic point-of-care glucose checks for accuracy. Triggers include planning glucose monitoring for inpatients with prior severe hypoglycemia, renal or hepatic dysfunction, or age 65 years or older.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md3.1 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Initiation of Inpatient Continuous Glucose Monitoring for Select Patients at High Hypoglycemia Risk

STEP 1 — Gather Information

Assess for high-risk hypoglycemia criteria: impaired awareness of hypoglycemia, age ≥65, type 1 diabetes, high-dose steroids, parenteral/enteral nutrition, isolation for contagious disease, CKD stage 3-5 or liver disease, comorbid conditions (cerebrovascular accident, malignancy, CHF, pancreatic disorder, infection), or history of preadmission/current hypoglycemia.
Document presence of any high-risk criterion.

STEP 2 — Rule In / Rule Out

Exclude patients with contraindications: hypotension/vasoconstriction, severe dehydration requiring vasopressors, edema/anascara, DKA/severe hyperglycemia, or substances interfering with CGM accuracy (e.g., vitamin C >4 g/day, hydroxyurea).
If patient meets any high-risk criterion and has no contraindications, proceed to CGM initiation; otherwise, rely on point-of-care glucose monitoring alone.

STEP 3 — Classify or Stratify

Classify all selected patients as requiring hybrid CGM use with periodic point-of-care glucose validation for accuracy.

STEP 4 — Decide

Initiate inpatient CGM device (e.g., Dexcom G6, Freestyle Libre), arrange for twice-daily point-of-care glucose checks for calibration/validation, ensure staff training and patient education on device use and alert response, integrate CGM data with the hospital EHR, and assign clear responsibility for interpreting and acting on CGM data.

Clinical Guardrails / Mimics / Pitfalls

Do not use CGM values alone for insulin dosing decisions; always confirm with point-of-care glucose before adjusting therapy. Avoid CGM in patients with hypotension, vasopressor therapy, severe dehydration, edema/anascara, DKA, or known interfering substances (high-dose vitamin C, hydroxyurea). Do not continue CGM during imaging or surgical procedures requiring device removal without a re‑application plan. Ensure hypoglycemia treatment protocols are followed regardless of CGM trends.

Concrete Clinical Example

A 72‑year‑old woman with type 2 diabetes and CKD stage 4 is admitted for pneumonia. She reports a prior episode of severe hypoglycemia requiring assistance. Screening shows no contraindications. Inpatient CGM (Dexcom G6) is initiated with twice‑daily fingerstick point‑of‑care glucose checks. Nursing staff receive training, the patient is educated on responding to alerts, CGM data flow into the EHR, and a nurse is assigned to review glucose trends and alerts each shift.

Source: Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2023, https://doi.org/10.1210/clinem/dgac596

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する